Fosl-2 has been shown to regulate profibrotic effects of TGF-β in dermal fibroblasts of patients with systemic sclerosis and in mouse models of scleroderma [43], but its role in the regulation of autophagy has not been acknowledged until now. Here, TGFB1 is linked to scleroderma.